THE Therapeutic Goods Administration has issued a product defect alert for two batches of Ospolot (sulthiame) 200mg tablets, over concerns child-resistant caps may not function correctly.
The above article was sent to subscribers in Pharmacy Daily's issue from 03 Jun 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 03 Jun 21